Is Exenatide a Treatment for Parkinson’s Disease? Athauda, Dilan. Wyse, Richard. Brundin, Patrik. Foltynie, Thomas. Journal of Parkinson's Disease. "There is growing interest in the use of glucagon-like peptide-1
agonists as treatments for Parkinson’s disease following the recent
publication...
Source: iospress.com
The glucagon‐like peptide 1 receptor agonist liraglutide attenuates the reinforcing properties of alcohol in rodents Vallöf, Daniel. Maccioni, Paola. Colombo, Giancarlo. Mandrapa, Minja. Jörnulf, Julia Winsa. Egecioglu, Emil. Engel, Jörgen A.. Jerlhag, Elisabet. Addiction Biology.
Source: wiley.com